[1]
National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. The Journal of allergy and clinical immunology. 2007 Nov:120(5 Suppl):S94-138
[PubMed PMID: 17983880]
[3]
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald JM, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. The European respiratory journal. 2008 Jan:31(1):143-78. doi: 10.1183/09031936.00138707. Epub
[PubMed PMID: 18166595]
[4]
Reddel HK, FitzGerald JM, Bateman ED, Bacharier LB, Becker A, Brusselle G, Buhl R, Cruz AA, Fleming L, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Pedersen SE, Sheikh A, Yorgancioglu A, Boulet LP. GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents. The European respiratory journal. 2019 Jun:53(6):. pii: 1901046. doi: 10.1183/13993003.01046-2019. Epub 2019 Jun 27
[PubMed PMID: 31249014]
[5]
Tashkin DP, Strange C. Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy? International journal of chronic obstructive pulmonary disease. 2018:13():2587-2601. doi: 10.2147/COPD.S172240. Epub 2018 Aug 27
[PubMed PMID: 30214177]
[6]
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J, Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American journal of respiratory and critical care medicine. 2007 Sep 15:176(6):532-55
[PubMed PMID: 17507545]
[7]
Allen DB, Bielory L, Derendorf H, Dluhy R, Colice GL, Szefler SJ. Inhaled corticosteroids: past lessons and future issues. The Journal of allergy and clinical immunology. 2003 Sep:112(3 Suppl):S1-40
[PubMed PMID: 14515117]
[8]
Geller DE. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Respiratory care. 2005 Oct:50(10):1313-21; discussion 1321-2
[PubMed PMID: 16185367]
[9]
van Geffen WH, Douma WR, Slebos DJ, Kerstjens HA. Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD. The Cochrane database of systematic reviews. 2016 Aug 29:2016(8):CD011826. doi: 10.1002/14651858.CD011826.pub2. Epub 2016 Aug 29
[PubMed PMID: 27569680]
Level 1 (high-level) evidence
[10]
Capanoglu M, Dibek Misirlioglu E, Toyran M, Civelek E, Kocabas CN. Evaluation of inhaler technique, adherence to therapy and their effect on disease control among children with asthma using metered dose or dry powder inhalers. The Journal of asthma : official journal of the Association for the Care of Asthma. 2015 Oct:52(8):838-45. doi: 10.3109/02770903.2015.1028075. Epub 2015 Jun 2
[PubMed PMID: 26037396]
[11]
Baptist AP, Reddy RC. Inhaled corticosteroids for asthma: are they all the same? Journal of clinical pharmacy and therapeutics. 2009 Feb:34(1):1-12. doi: 10.1111/j.1365-2710.2008.00970.x. Epub
[PubMed PMID: 19125898]
[12]
Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids. The American journal of medicine. 1995 Feb:98(2):196-208
[PubMed PMID: 7847437]
[13]
Lavy JA, Wood G, Rubin JS, Harries M. Dysphonia associated with inhaled steroids. Journal of voice : official journal of the Voice Foundation. 2000 Dec:14(4):581-8
[PubMed PMID: 11130115]
[14]
Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, Kohno S. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2003 Jun:90(6):646-51
[PubMed PMID: 12839324]
[15]
Simon MR, Houser WL, Smith KA, Long PM. Esophageal candidiasis as a complication of inhaled corticosteroids. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 1997 Oct:79(4):333-8
[PubMed PMID: 9357379]
[16]
Garcia-Cuesta C, Sarrion-Pérez MG, Bagán JV. Current treatment of oral candidiasis: A literature review. Journal of clinical and experimental dentistry. 2014 Dec:6(5):e576-82. doi: 10.4317/jced.51798. Epub 2014 Dec 1
[PubMed PMID: 25674329]
[17]
Heffler E, Madeira LNG, Ferrando M, Puggioni F, Racca F, Malvezzi L, Passalacqua G, Canonica GW. Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma. The journal of allergy and clinical immunology. In practice. 2018 May-Jun:6(3):776-781. doi: 10.1016/j.jaip.2018.01.025. Epub 2018 Feb 3
[PubMed PMID: 29408385]
[18]
Nowak-Wegrzyn A, Shapiro GG, Beyer K, Bardina L, Sampson HA. Contamination of dry powder inhalers for asthma with milk proteins containing lactose. The Journal of allergy and clinical immunology. 2004 Mar:113(3):558-60
[PubMed PMID: 15007361]
[19]
Robijn AL, Jensen ME, McLaughlin K, Gibson PG, Murphy VE. Inhaled corticosteroid use during pregnancy among women with asthma: A systematic review and meta-analysis. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2019 Nov:49(11):1403-1417. doi: 10.1111/cea.13474. Epub 2019 Sep 9
[PubMed PMID: 31357230]
Level 1 (high-level) evidence
[20]
Smy L, Chan AC, Bozzo P, Koren G. Is it safe to use inhaled corticosteroids in pregnancy? Canadian family physician Medecin de famille canadien. 2014 Sep:60(9):809-12, e433-5
[PubMed PMID: 25217675]